ClinicalTrials.Veeva

Menu

Lay-user Trial of the iGlucose Blood Glucose Monitoring System

N

Nina Peled

Status

Completed

Conditions

Diabetes Mellitus

Treatments

Device: Blood glucose monitor

Study type

Observational

Funder types

Industry

Identifiers

NCT02709707
CP00001

Details and patient eligibility

About

Evaluation of the iGlucose Blood Glucose Monitoring System in the hands of lay users

Full description

A non-randomized, prospective study of recruited subjects with diabetes. Subjects will include those with type I or type II diabetes of various duration and those who are naive to self-testing of blood glucose. Subjects will use provided instructions-for-use to undergo self-training on the use of the device and will then self-test their blood glucose level. Results will be compared to those obtained by a lab glucose analyzer.

Enrollment

153 patients

Sex

All

Ages

12+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Be 12 years of age and older
  • Have pre-existing diagnosis of diabetes
  • Be able to read and understand English
  • Agree to participate in the study
  • Be able and willing to provide informed consent

Exclusion criteria

  • Do not meet Inclusion Criteria
  • With Hemophilia or any other bleeding disorder
  • With any condition which in the opinion of the Investigator may place the subject or site staff at excessive risk
  • With physical condition/limitation preventing the use of SMBG on their own

Trial design

153 participants in 1 patient group

Patients with diabetes
Treatment:
Device: Blood glucose monitor

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems